Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes

Current Diabetes Reports
Christopher H Gibbons, Ann Goebel-Fabbri

Abstract

Aggressive glycemic control has become the standard clinical approach to diabetes care. Unintended consequences have included the development of microvascular complications that are related to the rapidity of glycemic improvement. Diabetic neuropathy may develop in up to 10% of individuals secondary to aggressive glycemic control. The neuropathy is predominantly small fiber sensory and autonomic, and the severity of the neuropathy is tied to the change in the glycosylated hemoglobin A1C. Other microvascular complications such as retinopathy and nephropathy are common and may occur in parallel with the neuropathy. Eating disorders are a common comorbid risk factor. Individuals with uncontrolled diabetes for prolonged periods, particularly those with a history of eating disorders involving insulin restriction for calorie purging, are at high risk for developing treatment-induced microvascular complications. Gradual glycemic improvements should be encouraged but future research is needed to optimize treatment and prevention strategies.

Associated Clinical Trials

References

Oct 1, 1992·Diabetes Care·R C PevelerD Dunger
Jan 1, 1989·Behaviour Research and Therapy·R C Peveler, C G Fairburn
Oct 1, 1988·Diabetes Care·J G LlewelynP Dandona
Jan 1, 1986·Acta Neuropathologica·J G LlewelynP Dandona
May 1, 1974·Diabetes·M Ellenberg
Oct 1, 1994·Diabetes Care·W H PolonskyC F Cole
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 13, 2003·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·E Chantelau, R Meyer-Schwickerath
Sep 26, 2003·Journal of Psychosomatic Research·Masato TakiiChiharu Kubo
Jan 31, 2006·Diabetes Care·Catherine L MartinUNKNOWN DCCT/EDIC Research Group
May 5, 2007·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·M D DavisF L Ferris
Dec 12, 2007·Diabetes Care·Ann E Goebel-FabbriKatie Weinger
Oct 14, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ron DabbyNathan Watemberg
Feb 13, 2010·Diabetes Care·James W AlbersUNKNOWN Diabetes Control and Complications Trial /Epidemiology of Diabetes Interventions and Complications Research Group
May 4, 2010·Annals of Neurology·Christopher H Gibbons, Roy Freeman
May 14, 2010·Current Diabetes Reports·Rodica Pop-BusuiUNKNOWN DCCT/EDIC Research Group
Jun 3, 2014·BMC Psychiatry·Nuria CustalFernando Fernandez-Aranda
Nov 14, 2014·Brain : a Journal of Neurology·Christopher H Gibbons, Roy Freeman
Oct 4, 2016·The American Psychologist·Mary de GrootJulie Wagner
Dec 22, 2016·Diabetes Care·Rodica Pop-BusuiDan Ziegler
Feb 6, 2017·Journal of Diabetes and Its Complications·Christopher H Gibbons

❮ Previous
Next ❯

Citations

Feb 6, 2020·Current Vascular Pharmacology·Michael DoumasVasilios G Athyros
Oct 2, 2020·Continuum : Lifelong Learning in Neurology·Christopher H Gibbons

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.